Navigation Links
More Doubt on Link Between a Blood Chemical and Heart Disease
Date:2/21/2012

TUESDAY, Feb. 21 (HealthDay News) -- Having high levels of the amino acid homocysteine won't raise your risk of developing heart disease, a new analysis indicates.

The findings appear to close the door on the potential benefit of lowering homocysteine levels with folic acid supplements, according to report author Robert Clarke, of the University of Oxford in the United Kingdom, and his colleagues.

The researchers also said previous studies that suggested high levels of homocysteine might be a modifiable risk factor for heart disease were plagued by publication bias and methodological problems.

Clarke and his team analyzed data on nearly 50,000 heart disease patients and 68,000 healthy people, culled from 86 published studies and 19 unpublished studies. There was no increased risk of heart disease in people who had an MTHFR gene variant that is associated with 20 percent higher blood homocysteine levels.

The MTHFR gene plays a role in the production of methylene tetrahydrofolate reductase, which uses folate to break down and remove homocysteine.

The study appears in this week's issue of the journal PLoS Medicine.

"The discrepancy between the overall results in the unpublished and the published datasets is too extreme to be plausibly dismissed as a chance finding," the researchers wrote. "Some studies, particularly if small, might have been prioritized for publication by investigators, referees or editors according to the positivity of their results and some may have been liable to other methodological problems that bias the average of all results. To avoid such biases, we chiefly emphasize the new results from the previously unpublished datasets."

"The magnitude of the effect of publication bias is substantial and, in addition to distorting the association of MTHFR with [coronary heart disease] in published studies, publication bias may also help explain the discrepant findings recently reported for MTHFR and stroke," they concluded.

More information

The U.S. National Heart Lung and Blood Institute has more about coronary heart disease.

-- Robert Preidt

SOURCE: PLoS Medicine, news release, Feb. 21, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Doubt Cast on Use of Genetic Test Before Plavix
2. Requests for Alzheimers disease research grants up by 33 percent, as federal funding in doubt
3. Study Casts Doubt on Hot Dogs Link to Colon Cancer
4. New Report Casts More Doubt on Virus Link to Chronic Fatigue Syndrome
5. Intensive care nurses have doubts about method for establishing brain death
6. Lifesaving antibiotics face doubtful future
7. Study Casts Doubt on Hospice Admission Criteria for Patients With Dementia
8. The balancing act between protection and inflammation in MS
9. UCLA scientists report link between traumatic brain injury, post-traumatic stress disorder
10. Molecular profiling reveals differences between primary and recurrent ovarian cancers
11. ROCK off: Study establishes molecular link between genetic defect and heart malformation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
More Doubt on Link Between a Blood Chemical and Heart Disease
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: